Product
JZP898
1 clinical trial
2 indications
Indication
Advanced Solid TumorIndication
Metastatic Solid TumorClinical trial
A Phase 1, First-in-human, Open-label, Multicenter Study of JZP898 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2027-11-30